Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCG”

408 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 408 results

Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268339
What this trial is testing

A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

Who this might be right for
High-Risk Non-Muscle Invasive Bladder Cancer
The Christie NHS Foundation Trust 328
Early research (Phase 1)Study completedNCT04563273
What this trial is testing

Clinical Study of BCG Vaccine for Intradermal Injection

Who this might be right for
Tuberculosis
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 160
Not applicableEnded earlyNCT06026332
What this trial is testing

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Who this might be right for
Bladder Cancer
Ferring Pharmaceuticals 202
Not applicableStudy completedNCT03526484
What this trial is testing

The Utility of Urinalysis Prior to In-Office Procedures

Who this might be right for
Urinary Tract Infections
University of Wisconsin, Madison 664
Testing effectiveness (Phase 2)Study completedNCT02692963
What this trial is testing

Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection

Who this might be right for
MalariaPlasmodium Falciparum
Radboud University Medical Center 20
Post-approval studies (Phase 4)Study completedNCT05168709
What this trial is testing

Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction

Who this might be right for
COVID-19Vaccine ReactionImmunization; Infection
Murdoch Childrens Research Institute 51
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Post-approval studies (Phase 4)Study completedNCT04641858
What this trial is testing

BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic

Who this might be right for
Covid19MorbidityAbsenteeism
University of Southern Denmark 668
Not applicableEnded earlyNCT02202044
What this trial is testing

Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection

Who this might be right for
Bladder Carcinoma
University of Colorado, Denver 13
Large-scale testing (Phase 3)Study completedNCT00052195
What this trial is testing

Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People

Who this might be right for
TuberculosisHIV Infections
Dartmouth-Hitchcock Medical Center 1,975
Large-scale testing (Phase 3)UnknownNCT01082510
What this trial is testing

Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)

Who this might be right for
Bladder Cancer
Urological Oncology Council of Northern Tokyo 288
Post-approval studies (Phase 4)Study completedNCT00146302
What this trial is testing

Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?

Who this might be right for
Tuberculosis
Bandim Health Project 2,320
Not applicableUnknownNCT04547738
What this trial is testing

Influence of Filarial Infections on Tuberculosis Disease and Tuberculosis Vaccination in Cameroon

Who this might be right for
Tuberculosis
University Hospital, Bonn 2,500
Large-scale testing (Phase 3)Study completedNCT04542330
What this trial is testing

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

Who this might be right for
Covid19Non-specific Effects of VaccinesHeterologous Immunity+3 more
Bandim Health Project 1,700
Early research (Phase 1)WithdrawnNCT06816017
What this trial is testing

Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT04373291
What this trial is testing

Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic

Who this might be right for
COVID-19Non-specific Effects of VaccinesMorbidity+2 more
Bandim Health Project 1,293
Testing effectiveness (Phase 2)Study completedNCT04172675
What this trial is testing

Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 107
Large-scale testing (Phase 3)Active Not RecruitingNCT04452591
What this trial is testing

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Who this might be right for
Non Muscle Invasive Bladder CancerHigh-grade Ta/ T1 Papillary Disease Bladder Cancer
CG Oncology, Inc. 190
Load More Results